736 related articles for article (PubMed ID: 32692070)
1. Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?
Fernandez LM; Figueiredo NL; Habr-Gama A; São Julião GP; Vieira P; Vailati BB; Nasir I; Parés O; Santiago I; Castillo-Martin M; Carvalho C; Parvaiz A; Perez RO
Dis Colon Rectum; 2020 Aug; 63(8):1053-1062. PubMed ID: 32692070
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
[TBL] [Abstract][Full Text] [Related]
3. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
[TBL] [Abstract][Full Text] [Related]
4. Local Regrowth and the Risk of Distant Metastases Among Patients Undergoing Watch-and-Wait for Rectal Cancer: What Is the Best Control Group? Multicenter Retrospective Study.
São Julião GP; Fernández LM; Vailati BB; Habr-Gama A; Azevedo JM; Santiago IA; Parés O; Parvaiz A; Vendrely V; Rullier A; Rullier E; Denost Q; Perez RO
Dis Colon Rectum; 2024 Jan; 67(1):73-81. PubMed ID: 37493198
[TBL] [Abstract][Full Text] [Related]
5. The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database.
Fernandez LM; São Julião GP; Renehan AG; Beets GL; Papoila AL; Vailati BB; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Figueiredo NL; Van De Velde CJH; Habr-Gama A; Perez RO;
Dis Colon Rectum; 2023 Jan; 66(1):41-49. PubMed ID: 36515514
[TBL] [Abstract][Full Text] [Related]
6. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy.
Chapman BC; Lai SH; Friedrich T; Lieu CH; Moskalenko M; Olsen JR; Herter W; Birnbaum EH; McCarter MD; Vogel JD
Dis Colon Rectum; 2023 Apr; 66(4):521-530. PubMed ID: 34984995
[TBL] [Abstract][Full Text] [Related]
7. Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes.
Meyer VM; Meuzelaar RR; Schoenaker IJH; de Groot JB; Reerink O; de Vos Tot Nederveen Cappel WH; Beets GL; van Westreenen HL
Dis Colon Rectum; 2023 May; 66(5):671-680. PubMed ID: 34856587
[TBL] [Abstract][Full Text] [Related]
8. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
[TBL] [Abstract][Full Text] [Related]
9. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
Park SY; Lee SM; Park JS; Kim HJ; Choi GS
Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
[TBL] [Abstract][Full Text] [Related]
10. Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma: Use, Risk Factors, and Outcomes in a Canadian Population.
Patel SV; Ko G; Raphael MJ; Booth CM; Brogly SB; Kalyvas M; Li W; Hanna T
Dis Colon Rectum; 2020 Jun; 63(6):748-757. PubMed ID: 32384405
[TBL] [Abstract][Full Text] [Related]
11. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
[TBL] [Abstract][Full Text] [Related]
12. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
[TBL] [Abstract][Full Text] [Related]
14. Oncological Outcomes of Transanal Endoscopic Surgery for the Surgical Management of T2 and T3 Rectal Cancer.
Johnson GGRJ; Robertson RL; Vergis A; Raval M; Phang T; Karimuddin A; Brown C
Dis Colon Rectum; 2023 Jul; 66(7):1012-1021. PubMed ID: 36876985
[TBL] [Abstract][Full Text] [Related]
15. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
Antunez AG; Kanters AE; Regenbogen SE
Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
[TBL] [Abstract][Full Text] [Related]
16. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
[TBL] [Abstract][Full Text] [Related]
17. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
[TBL] [Abstract][Full Text] [Related]
18. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
[TBL] [Abstract][Full Text] [Related]
19. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
Chin RI; Schiff JP; Shetty AS; Pedersen KS; Aranha O; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Byrnes K; Samson PP; Badiyan SN; Henke LE; Mutch MG; Kim H
Dis Colon Rectum; 2023 Jul; 66(7):973-982. PubMed ID: 36876988
[TBL] [Abstract][Full Text] [Related]
20. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
